The FDA has issued a warning letter to Par Health USA and Endo USA after an inspection revealed serious breaches of drug manufacturing safety rules, including flawed aseptic processes. The violations, ...
The Food and Drug Administration sent a warning letter to the makers of Ozempic and Wegovy for not reporting potential side effects of the drugs. The agency told Novo Nordisk it had “serious ...
The U.S. Food and Drug Administration has issued a warning letter to Novo Nordisk, accusing the Danish drugmaker behind blockbuster medications Ozempic and Wegovy of failing to properly report serious ...
RAPS: Analysis: OPDP More Likely to Issue Warning Letters if Drug has Black Box Warning
Analysis: OPDP More Likely to Issue Warning Letters if Drug has Black Box Warning
MSN: FDA issues ‘serious violations’ warning to Ozempic maker over unreported deaths
WSB-TV: FDA sends warning letter to Novo Nordisk over Ozempic, Wegovy side effects
FDA sends warning letter to Novo Nordisk over Ozempic, Wegovy side effects
Yahoo: FDA sends warning letter to Novo Nordisk over failure to report deaths, adverse side effects of GLP-1s
FDA sends warning letter to Novo Nordisk over failure to report deaths, adverse side effects of GLP-1s
Healio: FDA issues warning letter to Novo Nordisk for improper reporting of GLP-1 adverse events
FDA issues warning letter to Novo Nordisk for improper reporting of GLP-1 adverse events
Inc: FDA Issues ‘Serious Violations’ Warning to Ozempic Maker Over Unreported Deaths
MSN: FDA sends warning letter to Novo Nordisk over Ozempic, Wegovy side effects
WLWT: FDA sends warning letter to maker of Ozempic, Wegovy over unreported potential GLP-1 side effects